BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15517652)

  • 41. Alpha-fodrin auto-antibody in Sjögren syndrome and other auto-immune diseases in childhood.
    Takahashi K; Tatsuzawa O; Yanagi K; Hayashi Y; Takahashi H
    Eur J Pediatr; 2001 Aug; 160(8):520-1. PubMed ID: 11548195
    [No Abstract]   [Full Text] [Related]  

  • 42. Neonatal lupus erythematosus: maternal IgG antibodies bind to a recombinant NH2-terminal fusion protein encoded by human alpha-fodrin cDNA.
    Miyagawa S; Yanagi K; Yoshioka A; Kidoguchi K; Shirai T; Hayashi Y
    J Invest Dermatol; 1998 Dec; 111(6):1189-92. PubMed ID: 9856838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement.
    Mégevand P; Chizzolini C; Chofflon M; Roux-Lombard P; Lalive PH; Picard F
    Eur Neurol; 2007; 57(3):166-71. PubMed ID: 17213724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urban legends series: Sjögren's syndrome.
    Aframian DJ; Konttinen YT; Carrozzo M; Tzioufas AG
    Oral Dis; 2013 Jan; 19(1):46-58. PubMed ID: 22490059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
    Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
    J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel fragments of the Sjögren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death.
    Nagaraju K; Cox A; Casciola-Rosen L; Rosen A
    Arthritis Rheum; 2001 Oct; 44(10):2376-86. PubMed ID: 11665980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-alpha-fodrin antibodies in Sjögren syndrome and lupus erythematosus.
    Watanabe T; Tsuchida T; Kanda N; Mori K; Hayashi Y; Tamaki K
    Arch Dermatol; 1999 May; 135(5):535-9. PubMed ID: 10328193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Anti-carbonic anhydrase antibodies and primary Sjogren's syndrome].
    Cannone M
    G Ital Nefrol; 2011; 28(6):576. PubMed ID: 22167603
    [No Abstract]   [Full Text] [Related]  

  • 49. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome.
    Inoue H; Tsubota K; Ono M; Kizu Y; Mizuno F; Takada K; Yamada K; Yanagi K; Hayashi Y; Saito I
    J Immunol; 2001 May; 166(9):5801-9. PubMed ID: 11313424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies against alpha-fodrin are associated with dry eyes and mouth in the general population.
    Witte T; Bierwirth J; Schmidt RE; Matthias T
    J Rheumatol; 2006 Aug; 33(8):1713. PubMed ID: 16881136
    [No Abstract]   [Full Text] [Related]  

  • 52. [Epidermal IgG deposits in patients with primary Sjögren's syndrome].
    Oxholm A; Manthorpe R; Oxholm P
    Ugeskr Laeger; 1985 Jan; 147(4):261-4. PubMed ID: 3883608
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical and immunological factors associated with low lacrimal and salivary flow rate in patients with primary Sjögren's syndrome.
    Pijpe J; Kalk WW; Vissink A
    J Rheumatol; 2003 Jan; 30(1):206-7; author reply 207. PubMed ID: 12508418
    [No Abstract]   [Full Text] [Related]  

  • 54. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome?
    Baldini C; Giusti L; Bazzichi L; Lucacchini A; Bombardieri S
    Autoimmun Rev; 2008 Jan; 7(3):185-91. PubMed ID: 18190876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sjogren's syndrome.
    Soliotis FC; Moutsopoulos HM
    Autoimmunity; 2004 Jun; 37(4):305-7. PubMed ID: 15518047
    [No Abstract]   [Full Text] [Related]  

  • 56. [Sjögren's syndrome associated with a benign thymic tumor: report of a case with wide spectrum of clinical feature (author's transl)].
    Yoshida H; Matsuda S; Abe R; Kimura H; Shichishima T; Tanaka T; Akizuki T; Uchida T; Kariyone S
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):834-41. PubMed ID: 7234298
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes in glycosylation of immunoglobulins in primary Sjögren's syndrome.
    Basset C; Dueymes M; Devauchelle V; Mimassi NG; Pennec YL; Youinou P
    Ann Med Interne (Paris); 1998 Feb; 149(1):42-4. PubMed ID: 11490517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sjogren's syndrome. 2. Clinical associations and immunological phenomena.
    Whaley K; Webb J; McAvoy BA; Hughes GR; Lee P; MacSween RN; Buchanan WW
    Q J Med; 1973 Jul; 42(167):513-48. PubMed ID: 4580479
    [No Abstract]   [Full Text] [Related]  

  • 59. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.
    Haneji N; Nakamura T; Takio K; Yanagi K; Higashiyama H; Saito I; Noji S; Sugino H; Hayashi Y
    Science; 1997 Apr; 276(5312):604-7. PubMed ID: 9110981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgG/IgA pemphigus recognizing desmogleins 1 and 3 in a patient with Sjögren's syndrome.
    Furuya A; Takahashi E; Ishii N; Hashimoto T; Satoh T
    Eur J Dermatol; 2014; 24(4):512-3. PubMed ID: 25167567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.